Pacira Pharmaceuticals(DE:82P)
€32.400.00 (0.00%)
DE:82P
Pacira Pharmaceuticals earnings date
€32.40
At close:0.00 (0.00%)
Pacira Pharmaceuticals (82P) Q2 2021 Earnings Report
0 Followers
DE:82P Q2 2021 EPS Results
- Actual EPS
- EUR 0.69
- Consensus EPS
- EUR 0.63
- Beat/Miss
- Beat by +EUR 0.06
- One Year Ago EPS
- EUR 0.11
DE:82P Q2 2021 Revenue Results
- Actual Revenue
- EUR 121.40M
- Expected Revenue
- EUR 118.62M
- Beat/Miss
- Beat by +EUR 2.78M
- YoY Revenue Growth
- +79.58%
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 08/03/2021
- Time
- Before Open
- Conference Call
- Tuesday, August 3, 2021
DE:82P Upcoming Earnings
Pacira Pharmaceuticals's next earnings date is estimated for March 4, 2027, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:82P Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 04, 2027 | 2026 (Q4) | ―- | 0.51 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | 0.670.62 | 0.63 | -0.29% (-0.00) | |
| Aug 04, 2026 | 2026 (Q2) | 0.580.65 | 0.66 | -1.35% (-0.01) | |
| Apr 30, 2026 | 2026 (Q1) | 0.490.54 | 0.56 | -3.23% (-0.02) | |
| Feb 26, 2026 | 2025 (Q4) | 0.810.51 | 0.81 | -37.36% (-0.30) | |
| Nov 06, 2025 | 2025 (Q3) | 0.610.63 | 0.71 | -11.39% (-0.08) | |
| Aug 05, 2025 | 2025 (Q2) | 0.640.66 | 0.8 | -16.85% (-0.13) | |
| May 08, 2025 | 2025 (Q1) | 0.530.56 | 0.56 | 0.00% (+0.00) | |
| Feb 27, 2025 | 2024 (Q4) | 0.750.81 | 0.8 | 2.25% (+0.02) | |
| Nov 06, 2024 | 2024 (Q3) | 0.630.71 | 0.64 | 9.72% (+0.06) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

